返回 
加入收藏
吉非替尼诊断性治疗肺癌的疗效观察
x
请在关注微信后，向客服人员索取文件
| 篇名： | 吉非替尼诊断性治疗肺癌的疗效观察 |
| TITLE： | |
| 摘要： | 目的：观察分子靶向药物诊断性治疗肺癌的疗效。方法：选取在我院接受治疗的拟诊肺癌患者120例。所有患者采取常规辅助检查联合吉非替尼250 mg，qd诊断性治疗，4周为1个疗程，共治疗2个疗程。观察所有患者的疗效、症状改善情况、肺癌检出率、症状评分和生存质量评分。结果：所有患者有效率为91.67％，肺癌检出率为48.33％，有效率及检出率均较高；治疗后，所有患者症状评分均低于治疗前，生存质量量表评分优于治疗前，差异有统计学意义（P＜0.05）。结论：分子靶向药物诊断性治疗肺癌具有较高的有效率及检出率，有助于改善患者临床症状，提高其生存质量。 |
| ABSTRACT： | OBJECTIVE： To observe therapeutic efficacy of diagnostic treatment of molecular targeted drugs for lung cancer. METHODS： 120 cases of suspected lung cancer were selected in our hospital， and were given regular auxiliary examination combined with gefitinib 250 mg， qd， diagnostic treatment. A treatment course lasted for 4 weeks， and they received 2 courses of treatment. The therapeutic efficacy， symptom improvement， the rate of lung cancer detection， symptom score and quality of life score were observed. RESULTS： The effective rate of all patients was 91.67％， and lung cancer detection rate was 48.33％， two indicators were in high level； after treatment， symptom score of all patients was lower than before， while quality of life score was better than before， with statistical significance （P＜0.05）. CONCLUSIONS： The diagnostic treatment of molecular targeted drug for lung cancer has a high effective rate and detection rate， and help to improve clinical symptoms and the quality of life. |
| 期刊： | 2016年第27卷第2期 |
| 作者： | 秦泊洋，韩多林 |
| AUTHORS： | QIN Boyang，HAN Duolin |
| 关键字： | 吉非替尼；分子靶向药物；诊断性治疗；肺癌；疗效 |
| KEYWORDS： | Gefitinib； Molecular targeted drugs； Diagnostic treatment； Lung cancer； Efficacy |
| 阅读数： | 391 次 |
| 本月下载数： | 2 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
